D-0224-2025 Class II Ongoing
FDA drug recall D-0224-2025 was initiated by AvKARE on Jan 21, 2025 and is designated Class II. Reason for recall: Out of Specification for Dissolution The recall status is ongoing. Affected quantity: 341 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 19, 2025
- Initiation Date
- Jan 21, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 341 cartons
Product description
Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15
Reason for recall
Out of Specification for Dissolution
Distribution pattern
Nationwide in the USA
Code information
Lot 45279, Exp 03/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0224-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026